Patent · US Active

Noreugenin glycoside derivatives

US10722441B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2016
Grant dateJul 28, 2020
Priority date
Expiry dateDec 16, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2800/85
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A use of noreugenin glycoside derivatives of formulas I, II and III as a self-tanning substance or to increase the synthesis of melanin, improve melanin transport and/or improve the distribution of melanin in suprabasal layers, preparations containing noreugenin glycoside derivatives of formulas I, II and III, and noreugenin glycoside derivatives of formulas I, II and III.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.